Latest News

If you are wondering whether Teledyne Technologies at around US$623.80 is still a fair deal or already pricing in a lot of optimism, the valuation picture is the next thing to look at. The stock has seen mixed returns recently, with a 3.4% decline over the last 7 days and a 6.7% decline over the last 30 days, set against stronger figures of 20.2% year to date, 22.9% over 1 year, 46.0% over 3 years and 53.6% over 5 years. These returns sit alongside ongoing coverage of Teledyne Technologies...

Equinor (OB:EQNR) has agreed to acquire the 230 MW Esquina do Vento onshore wind project in Brazil. The transaction marks the company’s entry into Brazil’s onshore wind power market and expands its renewables portfolio. The project adds new generation capacity in Latin America, aligning with Equinor’s broader decarbonization ambitions. For investors tracking Equinor at NOK374.5 per share, the move comes after a period of strong share price performance, with the stock up 7.5% over the past...

Why Sysco Is On Investor Radars Today Sysco (SYY) is back in focus after recent trading, with the shares sitting near $81.60 and showing mixed short term performance, including a roughly 9% decline over the past month and a gain of more than 10% over the past three months. See our latest analysis for Sysco. For context, Sysco's recent 9.5% 1 month share price decline comes after a 10.3% 3 month share price return and a 17.4% 1 year total shareholder return. This suggests that earlier momentum...

Starbucks (NasdaqGS:SBUX) has dissolved its board-level committee focused on labor relations, bringing that oversight back to the full board. The move has renewed pressure from unions and some shareholders, including campaigns to vote against specific directors over governance and labor concerns. These developments come as Starbucks prepares to resume bargaining talks with organized workers, putting its labor approach under closer scrutiny. Starbucks, known for its global coffeehouse...

Index inclusion puts DRDGOLD in focus DRDGOLD (DRD) was recently added to the FTSE All-World Index in US$ terms, an event that can draw in passive index-tracking flows and broaden the shareholder base for the South Africa focused gold producer. See our latest analysis for DRDGOLD. The index inclusion comes after a strong 1 year total shareholder return of 99.22%. However, shorter term share price momentum has cooled, with a 30 day share price return showing a 24.14% decline and the stock now...

In recent weeks, Visa has moved to deepen its role in digital payments through initiatives such as its collaboration with Ingenico to link Android-based AXIUM smart POS terminals to the Visa Acceptance Platform and Citcon’s announcement of a tie-up with Visa Direct to expand push-payment capabilities for merchants across select markets. Alongside the launch of its Visa Agentic Ready AI-commerce program and fresh working-capital solutions for corporates, these moves highlight Visa’s push to...

Wondering if Old Dominion Freight Line is genuinely good value at around US$187.70 a share, or if the price has already run ahead of itself. The stock is at a last close of US$187.70, with returns of 2.9% over the past 7 days, a 6.8% decline over 30 days, 17.9% year to date, 11.2% over 1 year, 14.1% over 3 years, and 63.4% over 5 years. Recent market interest in Old Dominion Freight Line is being viewed through the lens of its role in the broader transportation sector and investor focus on...

Ubiquiti (UI) is back on investor radars after recent trading saw the stock close at US$809.36, with short term returns over the past week and month outpacing its longer term track record. See our latest analysis for Ubiquiti. The latest move builds on strong recent momentum, with a 1 day share price return of 5.76% contributing to a 42.93% year to date share price return and a 144.41% 1 year total shareholder return that has sharply outpaced shorter term gains. If you are looking beyond...

Qualys, Inc. (NasdaqGS:QLYS) has introduced Agent Val, an agent-led exploit validation and autonomous risk remediation solution. The new product is delivered within the company’s Enterprise TruRisk Management platform. Agent Val focuses on confirming real exploitability and automating remediation within existing security workflows. Qualys operates in cybersecurity, with a focus on vulnerability and risk management for enterprise customers. The launch of Agent Val fits into a broader shift...

Cosmo Pharmaceuticals at NVIDIA GTC: Why This AI Conference Matters for Investors Cosmo Pharmaceuticals (SWX:COPN) is set to present at the NVIDIA GTC AI Conference on March 19 in San Jose, putting its MedTech AI capabilities and GI Genius platform in front of a focused AI audience. See our latest analysis for Cosmo Pharmaceuticals. Cosmo’s share price has had a weak short term run, with a 30 day share price return of 33.31% decline and a year to date decline of 24.57%. However, the 1 year...

The alternative investment funds market has recently been reported as growing strongly, with forecasts suggesting it could reach US$21.35 billion by 2030, supported by demand for inflation-resilient and sustainability-focused assets. Brookfield Corporation is highlighted as one of the leading firms responding to this expansion by creating more advanced investment vehicles aimed at sophisticated investors, potentially broadening access to alternative assets. We’ll examine how Brookfield’s...

Why O'Reilly Automotive (ORLY) Is On Investors' Radar Today O'Reilly Automotive (ORLY) is drawing attention after recent trading left the shares with mixed short term returns, including a 1.6% gain over the past day but declines over the past week and month. See our latest analysis for O'Reilly Automotive. That 1.6% one-day share price gain to US$88.70 comes after a softer patch, with the 30-day share price return of 5.13% and year-to-date share price return of 1.82% pointing to fading...

General Electric (GE) has drawn investor attention after its shares closed at $291.54, with recent returns mixed over the past week, month and past 3 months. The question now is how this aligns with its current earnings profile. See our latest analysis for General Electric. While the recent 30-day share price return of negative 15.06% and year-to-date share price return of negative 9.11% point to fading short-term momentum, the 1-year and 5-year total shareholder returns of 39.41% and 362.90%...

CVS Health (CVS) is back in focus after a packed March, with a new Google Cloud partnership on healthcare technology, a fresh board appointment, an affirmed dividend, and a high profile class action targeting its PBM unit. See our latest analysis for CVS Health. Despite the headlines around the Google Cloud partnership, dividend affirmation, leadership change and PBM lawsuit, the share price has seen a 6% decline over the last 7 days and an 11% year to date share price decline, while the 1...

Wondering whether Mach Natural Resources at around US$13.73 is offering value or just noise? This article breaks down what the current price might imply for you as a shareholder or potential investor. The stock has been relatively steady in the short term, with a 0.4% decline over the last 7 days and a 0.8% return over 30 days, while still sitting on a 22.0% return year to date and 2.5% over the last year. Recent coverage has focused on Mach Natural Resources as an income focused oil and gas...

Opera (OPRA) shares are back in focus after the company outlined a new three year commercial framework with Celo, deepening its role in the Celo stablecoin ecosystem and extending support for the MiniPay wallet. See our latest analysis for Opera. Opera’s share price has gained 16.5% over the past month, while the 1 year total shareholder return is 18.5% lower and the 5 year total shareholder return stands at 80.8%. This suggests that recent momentum is rebuilding after a weaker year. If the...

If you are wondering whether Jacobs Solutions at around US$129 per share looks like a fair deal or not, this is a good moment to pause and look closely at the valuation. The stock is roughly flat over the last week at 0.3%, sits 6.3% lower over 30 days, is down 4.5% year to date, yet still shows a 7.0% return over 1 year, 40.8% over 3 years and 27.9% over 5 years. These mixed returns often reflect shifting views on long term project pipelines, capital allocation, or wider sentiment toward...

In March 2026, BioArctic and its partner Eisai presented new real-world and scientific data on Alzheimer’s drug lecanemab and BioArctic’s Parkinson’s research at the AD/PD Conference in Copenhagen, highlighting treatment persistence and mechanistic insights. The high proportion of early Alzheimer’s patients staying on lecanemab beyond 18 months, alongside BioArctic’s ongoing R&D presentations, underscores the company’s role in shaping emerging standards of care in neurodegenerative...

Microchip Technology (MCHP) has brought its BZPACK mSiC power modules to market and expanded its TA101 Trust Platform, underscoring a push into high-reliability power electronics and hardware-rooted cybersecurity for industrial and automotive uses. See our latest analysis for Microchip Technology. The recent product launches come as Microchip’s share price sits at US$64.34, with a 1-day share price return of 2.18% but a 30-day share price return showing a 17.23% decline. The 1-year total...

Baxter International Inc. was recently removed from the FTSE All-World Index and, earlier in March, announced the departure of its chief financial officer, Joel Grade, who will remain as an adviser until April 30, 2026. The appointment of experienced finance executive Anita Zielinski as interim CFO, alongside the index removal, raises fresh questions about governance continuity and how index-driven trading may influence Baxter’s investor base. Against this backdrop, we’ll explore how the...

Event driven snapshot on AGI (AGBK) AGI (AGBK), a Brazil-focused provider of technology-based financial services, has recently drawn investor attention after a roughly 23% decline over the past month, contrasting with its one-day gain and mixed weekly performance. See our latest analysis for AGI. The recent 1 day share price return of 2.34% comes after a 7 day share price return of 5.85% and a 30 day share price return of 23.44%. This leaves the year to date share price return at 14.60% and...

If you are wondering whether Planet Labs PBC is priced attractively after its recent surge, or if you are arriving late to the story, this article examines what the current share price might be implying about value. The stock last closed at US$33.82, with reported returns of 37.5% over 7 days, 41.5% over 30 days, 65.7% year to date, and around 7x over the past year. Recent coverage has focused on Planet Labs PBC's role as a provider of satellite imagery and data for government and commercial...

Wondering if ASML Holding at around €1,175 per share still makes sense for your portfolio, or if the price has run ahead of the fundamentals? The stock has had a mixed recent run, with a 1.8% decline over the past week and a 6.4% decline over the past month, while still showing a 19.2% gain year to date and a 75.8% return over the last year. Recent coverage has focused on ASML Holding's central role in supplying chipmaking equipment to major semiconductor producers and how that positioning...

If you are wondering whether Hims & Hers Health at around US$22.46 is a bargain or a value trap, the key is understanding what the current price actually reflects about the business. The stock has had a mixed run, with a 43.7% return over the past 30 days, set against a 9.7% decline over the past week and a 40.0% decline over the past year. Recent coverage has focused on Hims & Hers Health as a telehealth brand serving direct to consumer demand for health and wellness products, as well as on...